Avacta’s AffiDX SARS-CoV-2 test wins CE mark for consumer self-testing
Medusa will market the AffiDX SARS-CoV-2 antigen lateral flow self-test under the brand name MeduFlow
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Dec 21
Medusa will market the AffiDX SARS-CoV-2 antigen lateral flow self-test under the brand name MeduFlow
23 Dec 21
Lucira has received Interim Order authorization from Health Canada to sell and distribute its COVID-19 test kits for…
22 Dec 21
BD intends to make Scanwell the central digital platform to develop its at-home diagnostic tests for a wide…
20 Dec 21
Generate Life Sciences offers reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services
20 Dec 21
The non-invasive test is suitable for any individual, including those suspected of Covid-19 and those without symptoms
20 Dec 21
BD COR MX for infectious disease testing has been granted CE mark approval and is the final instrument…
20 Dec 21
Subject to positive study results, the number of patients currently enrolled in ECLIPSE is targeted to support a…
20 Dec 21
The simple test allows individuals to safely, quickly, and effectively obtain real-time measurements of their current COVID-19 immunity…
17 Dec 21
BioCode CoV-2 Flu Plus Assay uses nasopharyngeal swab specimens and runs on a high-throughput BioCode MDx-3000 molecular system
16 Dec 21
The AffiDX® SARS-CoV-2 antigen lateral flow test has been evaluated at the Carlos III Hospital in Madrid using…